April 10-12, 2019 in Oxon Hill, Maryland USA

World Orphan Drug Congress USA focusses on the most pressing challenges and opportunities to bring rare disease therapies to patients faster. Bringing together a global gathering of 1,200 leaders in orphan drugs from 50 countries, World Orphan Drug Congress USA will feature over 135 presentations covering all aspects of orphan drug development and rare disease research. Matthew Letow, Director of Business Development for ICS will be in attendance if you would like to reach out to set-up a meeting please submit the form below.